Publications
Can knowledge-based planning models validated on ethnically diverse patients lead to global standardisation of external beam radiation therapy for locally advanced cervix cancer?
Jain J, Serban M, Assenholt MS, Tanderup K, Chopra S
Radiotherapy and Oncology, 204: 110694, 2025
RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials
Charnalia M, Chopra S, Mulani J, Popat P, Rath S, Thomeer M, Mittal P, Gupta A, Boere I, Gupta S, Nout RA
International Journal of Gynecological Cancer, 34(6): 817-23, 2024
Drug repurposing as a potential source of innovative therapies in cervical cancer
Paul S, Boere I, Pantziarka P, Chopra S, Nout RA, Bouche G
International Journal of Gynecological Cancer, 32(11): 1377-86, 2022
Months and Severity Score (MOSES) in a Phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trials
Ranjan N, Chopra S, Mangaj A, Rane P, Charnalia M, Kannan S, Dora T, Engineer R, Mahantshetty U, Gurram L, Mittal P
EClinicalMedicine, 47, 2022
A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer
Horeweg N, Mittal P, Gradowska PL, Boere I, Nout RA, Chopra S
Critical Reviews in Oncology/Hematology, 172: 103638, 2022
Defining the role of high-dose radiation in oligometastatic & oligorecurrent cervical cancer
Mangaj A, Chopra S, Nout RA
Indian Journal of Medical Research, 154(2): 303-18, 2021
Adjuvant systemic therapy after chemoradiation and brachytherapy for locally advanced cervical cancer: a systematic review and meta-analysis
Horeweg N, Mittal P, Gradowska PL, Boere I, Chopra S, Nout RA
Cancers, 13(8): 1880, 2021